Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.

Abstract

In a controlled double-blind study practolol, a new cardioselective beta-blocking drug, was given to 15 patients with angina pectoris, and compared with propranolol 80 mg. q.d.s. The dose of practolol ranged from 200 to 600 mg.b.d. and was decided by initial open titration in individual patients. Though practolol did not influence the incidence of angina or… (More)

Topics

6 Figures and Tables

Slides referencing similar topics